Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus
Authors:
- Ellen K. HoogeveenEHEllen K. Hoogeveen
- Pieter J. KostensePKPieter J. Kostense
- Petra E. D. EysinkPEPetra E. D. Eysink
- Bettine C. P. PolakBPBettine C. P. Polak
- Pieter J. BeksPBPieter J. Beks
- Cornelis JakobsCJCornelis Jakobs
- Jacqueline M. DekkerJDJacqueline M. Dekker
- Giel NijpelsGNGiel Nijpels
- Robert J. HeineRHRobert J. Heine
- Lex M. BouterLBLex M. Bouter
- Coen D. A. StehouwerCSCoen D. A. Stehouwer
Open Access
- 23 October 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (19) , 2984-2990
Abstract
DIABETIC retinopathy is the leading cause of blindness among patients with type 2 diabetes mellitus (DM).1,2 About one third of all cases of impaired visual function in patients with type 2 DM is attributable to retinopathy, the remainder to cataract, glaucoma, macular degeneration, and other causes. Blindness has been estimated to be 25 times more common in persons with DM than in those without DM.3 After 20 years of having DM, more than 60% of the patients with type 2 DM have some degree of retinopathy.2 The pathogenetic mechanisms of diabetic retinopathy are incompletely understood.Keywords
This publication has 1 reference indexed in Scilit: